It provides strong support for the adoption of BT as a new therapeutic option for the treating serious asthma in adults. .. AIR Trial demonstrates benefits of BT in asthma patients Asthmatx Inc. The info demonstrated the lack of clinical problems and the maintenance of stable lung function over a five calendar year period post-BT in individuals with moderate to severe asthma. The data was shown in a poster at the annual achieving of the American Thoracic Society in New Orleans. Gerard Cox, Professor of Medicine, McMaster University and lead author of the poster.The goal of this collaborative research effort – which includes support from the Michael J also. Fox Base, the National Parkinson Base and the Parkinson’s Institute – is to discover how genes and the surroundings influence Parkinson’s disease. We are aware of the limitations of today’s treatments, so we are always thinking about what we are able to do to progress the care of the incurable disease, said Andre Machado, M.D., Ph.D., Director of Cleveland Clinic’s Middle for Neurological Restoration. This collaboration will help us to learn more about the genomics of Parkinson’s disease and how it could impact individualized care later on.